Dennis McBride - Apr 9, 2025 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Dennis McBride
Stock symbol
NRXP
Transactions as of
Apr 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/10/2025, 03:35 PM
Previous filing
Jun 26, 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McBride Dennis Director C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE STREET STE 600, WILMINGTON /s/ Dennis McBride 2025-09-10 0002028250

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRXP Stock Option (right to buy) Award $0 +25K $0.00 25K Apr 9, 2025 Common Stock 25K $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer.